Patient-Provider Discussions About Out-of-Pocket Costs of Cancer Care in the U.S.
Journal
American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
26
09
2019
revised:
16
02
2020
accepted:
17
02
2020
pubmed:
18
5
2020
medline:
16
6
2021
entrez:
18
5
2020
Statut:
ppublish
Résumé
Despite the importance of cost-related discussions in cancer care, little is known about the prevalence or drivers of these discussions in clinical practice. This study estimates the prevalence and examines the correlates of cancer survivors' discussions about out-of-pocket costs of cancer care with providers. The 2016 and 2017 Medical Expenditure Panel Survey Experiences with Cancer Surveys were used to identify 1,550 survivors who responded to the question on discussion about out-of-pocket costs of cancer care. Multivariable multinomial logistic regression examined the correlates of discussions about out-of-pocket costs. Analyses were performed in 2019. Approximately one quarter of cancer survivors reported having discussed the out-of-pocket costs of cancer care. In multivariable analyses, respondents in the following categories were less likely to report no cost discussion than any cost discussion: black non-Hispanic/other race (RRR=0.67, 95% CI=0.45, 0.98; white non-Hispanic race as reference), no health insurance at diagnosis (RRR=0.51, 95% CI=0.27, 0.95; private health insurance as reference), and any experience of financial hardship (RRR=0.48, 95% CI=0.35, 0.66; no financial hardship as reference). Patient-reported discussions about out-of-pocket costs for cancer care are infrequent in the U.S. The findings highlight the needs to improve the understanding of the barriers and facilitators for effective discussions about out-of-pocket costs of cancer care.
Identifiants
pubmed: 32417019
pii: S0749-3797(20)30134-3
doi: 10.1016/j.amepre.2020.02.017
pmc: PMC9278513
mid: NIHMS1818544
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
228-236Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Copyright © 2020 American Journal of Preventive Medicine. All rights reserved.
Références
Med Care. 2014 Jul;52(7):594-601
pubmed: 24926706
J Clin Oncol. 2011 Jun 20;29(18):2534-42
pubmed: 21606426
Oncologist. 2010;15(6):584-92
pubmed: 20495217
J Oncol Pract. 2012 Jul;8(4):e50-8
pubmed: 23180999
N Engl J Med. 2010 Apr 29;362(17):1553-5
pubmed: 20375400
J Oncol Pract. 2014 May;10(3):162-7
pubmed: 24839274
J Clin Oncol. 2007 Jan 10;25(2):233-7
pubmed: 17210946
Am J Manag Care. 2015 Sep;21(9):607-15
pubmed: 26618364
J Oncol Pract. 2015 Mar;11(2):145-50
pubmed: 25515717
J Oncol Pract. 2017 Apr;13(4):e353-e394
pubmed: 28326862
Health Aff (Millwood). 2013 Jun;32(6):1143-52
pubmed: 23676531
J Clin Oncol. 2016 Mar 20;34(9):980-6
pubmed: 26811521
J Oncol Pract. 2017 Nov;13(11):e944-e956
pubmed: 28834684
Cancer. 2017 May 15;123(6):928-939
pubmed: 27893929
Med Decis Making. 2016 Oct;36(7):900-10
pubmed: 26785714
Cancer. 2019 May 15;125(10):1737-1747
pubmed: 30663039
J Clin Oncol. 2009 Aug 10;27(23):3868-74
pubmed: 19581533
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):308-317
pubmed: 31941708
J Oncol Pract. 2017 Mar;13(3):e249-e258
pubmed: 27960067
Oncologist. 2013;18(4):381-90
pubmed: 23442307
J Oncol Pract. 2016 Mar;12(3):e281-8, 247-8
pubmed: 26883407
J Oncol Pract. 2015 Jul;11(4):308-12
pubmed: 26015459
Am J Manag Care. 2009 Nov;15(11):801-6
pubmed: 19895184
Oncologist. 2015 Oct;20(10):1199-204
pubmed: 26330457
J Clin Oncol. 2013 Oct 20;31(30):3749-57
pubmed: 24043731
Cancer. 2011 Jun 15;117(12):2791-800
pubmed: 21656757
Oncologist. 2014 Nov;19(11):1135-40
pubmed: 25273078
Health Aff (Millwood). 2016 Apr;35(4):654-61
pubmed: 27044966